Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 154. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI59% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_2AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI56% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_3AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI49% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_4AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI90% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_5AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI78% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_6AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI78% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_7AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI70% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_8AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI60% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_9AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI38% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_1406ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (12.5 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.5 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1407ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (12.5 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI35% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1410ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1411ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1412ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI60% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1413ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1414ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1415ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI65% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1416ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1417ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1418ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI65% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1419ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1420ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1421ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI45% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1422ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1423ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1424ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1425ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI42% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1426ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI42% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1427ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI40% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1428ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1429ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1430ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1431ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1432ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1433ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1434ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1435ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1436ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1878Herpes simplex virusNV1059DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1879Herpes simplex virusNV1060DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1880Herpes simplex virusNV1061DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1881Herpes simplex virusNV1062DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI80% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1882Herpes simplex virusNV1063DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.037 MOI80% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1883Herpes simplex virusNV1064DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.037 MOI80% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1884Herpes simplex virusNV1065DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.037 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1885Herpes simplex virusNV1066DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.037 MOI78% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1886Herpes simplex virusNV1067DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.11 MOI90% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1887Herpes simplex virusNV1068DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.11 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1888Herpes simplex virusNV1069DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.11 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1889Herpes simplex virusNV1070DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.11 MOI60% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1890Herpes simplex virusNV1071DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.33 MOI60% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1891Herpes simplex virusNV1072DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.33 MOI80% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1892Herpes simplex virusNV1073DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.33 MOI65% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1893Herpes simplex virusNV1074DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.33 MOI60% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1894Herpes simplex virusNV1075DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay1 MOI60% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1895Herpes simplex virusNV1076DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay1 MOI60% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1896Herpes simplex virusNV1077DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay1 MOI40% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1897Herpes simplex virusNV1078DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay1 MOI30% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1898Herpes simplex virusNV1079DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay3 MOI60% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1899Herpes simplex virusNV1080DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay3 MOI50% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1900Herpes simplex virusNV1081DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay3 MOI30% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1901Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay3 MOI20% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1902Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneNoVirus alongwith radiation 2.5 GyNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.1 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1903Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneNoVirus alongwith radiation 5 GyNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.2 MOI35% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1904Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneNoVirus alongwith radiation 10 GyNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.4 MOI30% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1905Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneNoVirus alongwith radiation 20 GyNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.8 MOI20% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1906Herpes simplex virusNV1082DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneNoVirus alongwith radiation 40 GyNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay1.6 MOI15% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_2271Vesicular stomatitis viruswild typeRNARhabdoviridaeNoneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay1 MOI100% cell death after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2285Vesicular stomatitis virusVSV-Delta-M51-GFPRNARhabdoviridaeDeletion of M51 gene and insertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay1 MOI5% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2299Vesicular stomatitis virusVSV-p1-GFPRNARhabdoviridaeInsertion of P geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay1 MOI98% cell death after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2313Vesicular stomatitis virusSev-GFPRNARhabdoviridaeInsertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay1 MOI10% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2327Vesicular stomatitis virusRSV-GFPRNARhabdoviridaeInsertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay1 MOI20% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2341Vesicular stomatitis viruswild typeRNARhabdoviridaeNoneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay0.01 MOI5% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2355Vesicular stomatitis virusVSV-Delta-M51-GFPRNARhabdoviridaeDeletion of M51 gene and insertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay0.01 MOI5% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2369Vesicular stomatitis virusVSV-p1-GFPRNARhabdoviridaeInsertion of P geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay0.01 MOI5% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2383Vesicular stomatitis virusSev-GFPRNARhabdoviridaeVirus expressing GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay0.01 MOI40% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2397Vesicular stomatitis virusRSV-GFPRNARhabdoviridaeVirus expressing GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-180% confluent monolayerNAMTT assay0.01 MOI80% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2409Vesicular stomatitis virusVSV-Delta-M51-GFPRNARhabdoviridaeDeletion of M51 gene and insertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell linePANC-1NANANANANAAthymic mice xenograft for MIA PANC-1 cell line5 × 10⁷ pfu NA Reduction in tumor weight below 200 mg after 25 daysIntratumoralNADownregulation of IFN-GammaNA22238308
OV_2417Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2418Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2419Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI90% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2420Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI20% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2421Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell killing after day 9NoNoNA No responseNANANANA22258815
OV_2457Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2458Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2459Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI50% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2460Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI10% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2461Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell death after day 9NoNoNA No responseNANANANA22258815
OV_2495Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer1 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2496Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer1 MOI30% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2497Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer1 MOI95% cell killing after day 5NoNoNA No responseNANANANA22258815
OV_2498Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer1 MOI100% cell killing after day 5NoNoNA No responseNANANANA22258815
OV_2526Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1NANANANANAHsd:athymic nude mice xenografted for PANC-1 cell line(2.0E+6 cells)2.0E+6 pfuNA Decrease in tumor volume below 2 after 34 daysIntratumoralNANANA22258815
OV_2527Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1NANANANANAHsd:athymic nude mice xenografted for PANC-1 cell line(2.0E+6 cells)2.0E+6 pfuNA Decrease in tumor volume below 2 after 34 daysIntravenousNANANA22258815
OV_3419Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.01 MOINo cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3420Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.05 MOI80% cell survival after 72 hoursNoNoNA No responseNANANANA28607950
OV_3421Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNANANANA28607950
OV_3422Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.5 MOI50% cell survival after 72 hoursNoNoNA No responseNANANANA28607950
OV_3423Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay1 MOI30% cell survival after 72 hoursNoNoNA No responseNANANANA28607950
OV_3430Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with gemcitabine (7.5 × 10⁻² micromolar) after 1 hourNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI75% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3431Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with gemcitabine (7.5 × 10⁻² micromolar) after 24 hourNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI75% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3438Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (5 × 10⁻³ micromolar) after 1 hourNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI50% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3439Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (5 × 10⁻³ micromolar) after 24 hourNoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI60% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3458Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.075 MOI75% cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3459Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.1 MOI75% cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3460Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNASRB assay0.125 MOI72% cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3461Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNACTB assay0.075 MOI72% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3462Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNACTB assay0.1 MOI70% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3463Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (37.5 nM)NoATCCHuman pancreatic adenocarcinoma cell linePANC-14.0E+4 cells per wellNACTB assay0.125 MOI70% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3741Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.0001 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3742Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.001 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3743Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.01 MOI80% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3744Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay1 MOI20% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3745Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay2 MOI100% cell killing after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3746Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay3 MOI100% cell killing after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3759Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (1 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.1 MOI70% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3760Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (1 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.5 MOI50% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3761Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (5 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.1 MOI40% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3762Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (5 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.5 MOI20% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_4136AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4137AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4138AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100 vp/cell70% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4139AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4140AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4141AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4142AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4143AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4144AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4145AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1000 vp/cell40% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4146AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10000 vp/cell10% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4147AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4297AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas epithelioid carcinomaPANC-14000 cells per wellNAMTT assay10 pfu49.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_5082AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay1 MOI100% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5083AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay2 MOI80% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5084AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay4 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5085AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay8 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5086AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay16 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5087AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 5ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay1 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5088AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 10ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay2 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5089AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 20ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay4 MOI50% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5090AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 40ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay8 MOI40% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5091AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 80ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell linePANC-11.0E+4 cells per wellNAMTT assay16 MOI30% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5351AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneYesNoNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.1 MOI100% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5352AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneYesNoNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.5 MOI100% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5353AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with gemcitabine 0.01 micromoarNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.1 MOI70% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5354AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with gemcitabine 0.01 micromoarNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.5 MOI68% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5355AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with gemcitabine 0.05 micromoarNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.1 MOI65% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5356AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with gemcitabine 0.05 micromoarNoATCCHuman pancreatic cancer cell linePANC-15.0E+3 cells per wellNAMTT assay0.5 MOI50% cell viability after 72 hoursNoNoNA No responseNAVirus induced apoptosisNANA28315430
OV_5560Sindbis virusAR339RNATogaviridaeNoneYesNoNoNAHuman pancreatic cell linePANC-11.0E+5 cells per wellNANA1 MOISignificant death of cancer cell line after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5565Reoviruswild typeRNAReoviridaeNoneYesNoNoNAHuman pancreatic cell linePANC-11.0E+5 cells per wellNANA1 MOISignificant death of cancer cell line after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5570Sindbis virusAR339RNATogaviridaeNoneNoSindbis virus in combination with ReovirusNoNAHuman pancreatic cell linePANC-11.0E+5 cells per wellNANA1 MOIEnhancer cytolytic effect in combination after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5592Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman pancreatic carcinoma cell linePANC-180% confluencyNAMTT assay3 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5902Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman pancreatic cancer cell linePANC-15E+5 pfuNALDH release assay0.1 MOI50% of cancer cell death occurs after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5904Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman pancreatic cancer cell linePANC-15E+5 pfuNALDH release assay0.1 MOI100% cell killing observed after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984